HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders
Breast Cancer Update
00:00
ESR1 emergence timing and CDK4/6 context
Hamilton discusses when ESR1 mutations arise, influence of prolonged AI±CDK4/6 exposure and resistance dynamics.
Play episode from 11:52
Transcript
